{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:48:34Z","timestamp":1784738914486,"version":"3.55.0"},"reference-count":74,"publisher":"Bentham Science Publishers Ltd.","issue":"12","funder":[{"DOI":"10.13039\/501100007341","name":"Chhattisgarh Council of Science & Technology","doi-asserted-by":"publisher","award":["CCOST\/MRP\/1106\/2015"],"award-info":[{"award-number":["CCOST\/MRP\/1106\/2015"]}],"id":[{"id":"10.13039\/501100007341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007341","name":"Chhattisgarh Council of Science & Technology","doi-asserted-by":"publisher","award":["CCOST\/MRP\/1120\/2015"],"award-info":[{"award-number":["CCOST\/MRP\/1120\/2015"]}],"id":[{"id":"10.13039\/501100007341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2020,9,18]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Lymphatic filariasis is a pervasive and life-threatening disease for human beings. Currently, 893 million people in 49 countries worldwide affected by lymphatic filariasis as per WHO statistics. The concealed aspects of lymphatic diseases such as delayed disease detection, inappropriate disease imaging, the geographical outbreak of infection, and lack of preventive chemotherapy have brought this epidemic to the edge of Neglected Tropical Diseases. Many medications and natural bioactive substances have seen to promote filaricidal activity against the target parasitic species. However, the majority of failures have occurred in pharmaceutical and pharmacokinetic issues.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>The purpose of the study is to focus on the challenges and therapeutic issues in the treatment of filariasis. The review brings novel techniques and therapeutic approaches for combating lymphatic filariasis. It also offers significant developments and opportunities for such therapeutic interventions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Through this review, an attempt has made to critically evaluate the avenues of innovative pharmaceuticals and molecular targeting approaches to bring an integrated solution to combat lymphatic filariasis.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389450121666200630111250","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T18:44:11Z","timestamp":1593542651000},"page":"1250-1263","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Epitome of Novel Techniques and Targeting Approaches in Drug Delivery for Treating Lymphatic Filariasis"],"prefix":"10.2174","volume":"21","author":[{"given":"Saurabh","family":"Shrivastava","sequence":"first","affiliation":[{"name":"Shri Rawatpura Sarkar Institute of Pharmacy, Kumhari, Durg, Chhattisgarh, 490042, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshita","family":"Gupta","sequence":"additional","affiliation":[{"name":"Shri Rawatpura Sarkar Institute of Pharmacy, Kumhari, Durg, Chhattisgarh, 490042, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanchal Deep","family":"Kaur","sequence":"additional","affiliation":[{"name":"Shri Rawatpura Sarkar Institute of Pharmacy, Kumhari, Durg, Chhattisgarh, 490042, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"2733","volume":"8","author":"Ali Khan A.","year":"2013","unstructured":"Ali Khan A.; Mudassir J.; Mohtar N.; Darwis Y.; Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomedicine 2013,8,2733-2744","journal-title":"Int J Nanomedicine"},{"key":"ref=2","first-page":"445","volume":"Sep; 5","author":"Shrivastava S","year":"2016","unstructured":"Shrivastava S; Gidwani B; Gupta A; Kaur CD; Ethnopharmacological approaches to treat lymphatic filariasis. International Journal of Pharmacy and Analytical Research .2320 -2831 Google Scholar2016,Sep; 5(3),445-470","journal-title":"International Journal of Pharmacy and Analytical Research"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"E65","DOI":"10.1055\/a-0918-3678","volume":"5","author":"Dietrich C.F.","year":"2019","unstructured":"Dietrich C.F.; Chaubal N.; Hoerauf A.; Kling K.; Piontek M.S.; Steffgen L.; Mand S.; Dong Y.; Review of dancing parasites in lymphatic filariasis. Ultrasound Int Open 2019,5(2),E65-E74","journal-title":"Ultrasound Int Open"},{"key":"ref=4","year":"2019","unstructured":"Lymphatic filariasis. 2019"},{"key":"ref=5","author":"NVBDC Filariasis","year":"2019 26 August","unstructured":"NVBDC Filariasis ; [26 August 2019]2019 26 August"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/1061186X.2013.832766","volume":"22","author":"Ali M.","year":"2014","unstructured":"Ali M.; Afzal M.; Kaushik U.; Bhattacharya S.M.; Ahmad F.J.; Dinda A.K.; Perceptive solutions to anti-filarial chemotherapy of lymphatic filariasis from the plethora of nanomedical sciences. J Drug Target 2014,22(1),1-13","journal-title":"J Drug Target"},{"key":"ref=7","author":"Tripathi KD","year":"2013","unstructured":"Tripathi KD; Essentials of medical pharmacology; JP Medical Ltd, 30.Sep; Book2013"},{"key":"ref=8","author":"Rang HP","year":"2014","unstructured":"Rang HP; Ritter JM; Flower RJ; Henderson, G Rang & Dale's Pharmacology E-Book; Elsevier Health Sciences, 2Dec; Book2014"},{"key":"ref=9","first-page":"1020","volume":"2","author":"Pharmacopoeia I.","year":"2007","unstructured":"Pharmacopoeia I.; Government of India. Ministry of health and family welfare 2007,2,1020-1021","journal-title":"Ministry of health and family welfare"},{"key":"ref=10","author":"Goodman L.S.","year":"1996","unstructured":"Goodman L.S.; Book1996"},{"key":"ref=11","author":"Katzung B.G.","year":"2017","unstructured":"Katzung B.G.; Basic and clinical pharmacology McGraw-Hill Education 2017","journal-title":"Basic and clinical pharmacology McGraw-Hill Education"},{"key":"ref=12","author":"Howland R.D.","year":"2006","unstructured":"Howland R.D.; Mycek M.J.; Harvey R.A.; Champe P.C.; Lippincott's illustrated reviews: Pharmacology; Lippincott Williams Book2006","journal-title":"Lippincott's illustrated reviews: Pharmacology; Lippincott Williams"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/RRTM.S125204","volume":"9","author":"Gyapong J.O.","year":"2018","unstructured":"Gyapong J.O.; Owusu I.O.; da-Costa Vroom F.B.; Mensah E.O.; Gyapong M.; Elimination of lymphatic filariasis: current perspectives on mass drug administration. Res Rep Trop Med 2018,9,25-33","journal-title":"Res Rep Trop Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.fjps.2018.04.001","volume":"4","author":"Poovi G.","year":"2018","unstructured":"Poovi G.; Damodharan N.; Lipid nanoparticles: A challenging approach for oral delivery of BCS Class-II drugs. Future Journal of Pharmaceutical Sciences 2018,4(2),191-205","journal-title":"Future Journal of Pharmaceutical Sciences"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02726351.2020.1750515","author":"Shrivastava S.","year":"2020","unstructured":"Shrivastava S.; Gidwani B.; Kaur C.D.; Development of mebendazole loaded nanostructured lipid carriers for lymphatic targeting: Optimization, characterization, in-vitro and in-vivo evaluation. Particul Sci Technol 2020,1-1","journal-title":"Particul Sci Technol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1080\/10611860802475688","volume":"16","author":"Kaur C.D.","year":"2008","unstructured":"Kaur C.D.; Nahar M.; Jain N.K.; Lymphatic targeting of zidovudine using surface-engineered liposomes. J Drug Target 2008,16(10),798-805","journal-title":"J Drug Target"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajps.2013.07.012","volume":"8","author":"Kim H","year":"2013 1Apr","unstructured":"Kim H; Kim Y; Lee J; Liposomal formulations for enhanced lymphatic drug delivery asian journal of pharmaceutical sciences 2013 1Apr,8(2),96-103","journal-title":"Liposomal formulations for enhanced lymphatic drug delivery asian journal of pharmaceutical sciences"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.colsurfb.2017.10.057","volume":"161","author":"Roy P.","year":"2018","unstructured":"Roy P.; Saha S.K.; Gayen P.; Chowdhury P.; Sinha Babu S.P.; Exploration of antifilarial activity of gold nanoparticle against human and bovine filarial parasites: A nanomedicinal mechanistic approach. Colloids Surf B Biointerfaces 2018,161,236-243","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1007\/s00436-013-3466-4","volume":"112","author":"Ali M.","year":"2013","unstructured":"Ali M.; Afzal M.; Verma M.; Misra-Bhattacharya S.; Ahmad F.J.; Dinda A.K.; Improved antifilarial activity of ivermectin in chitosan-alginate nanoparticles against human lymphatic filarial parasite, Brugia malayi. Parasitol Res 2013,112(8),2933-2943","journal-title":"Parasitol Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3923\/rjnn.2011.60.74","volume":"1","author":"Saraf S.","year":"2011","unstructured":"Saraf S.; Ghosh A.; Kaur C.D.; Saraf S.; Novel modified nanosystem based lymphatic targeting. Res J Nanosci Nanotechnol 2011,1,60-74","journal-title":"Res J Nanosci Nanotechnol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0378-5173(96)04798-9","volume":"147","author":"Kim C.K.","year":"1997","unstructured":"Kim C.K.; Jeong E.J.; Enhanced lymph node delivery and immunogenicity of hepatitis B surface antigen entrapped in galactosylated liposomes. Int J Pharm 1997,147(2),143-151","journal-title":"Int J Pharm"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1517\/17425247.2014.866088","volume":"11","author":"Singh I.","year":"2014","unstructured":"Singh I.; Swami R.; Khan W.; Sistla R.; Lymphatic system: a prospective area for advanced targeting of particulate drug carriers. Expert Opin Drug Deliv 2014,11(2),211-229","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1002\/jps.20163","volume":"93","author":"Medina L.A.","year":"2004","unstructured":"Medina L.A.; Calixto S.M.; Klipper R.; Phillips W.T.; Goins B.; Avidin\/biotin-liposome system injected in the pleural space for drug delivery to mediastinal lymph nodes. J Pharm Sci 2004,93(10),2595-2608","journal-title":"J Pharm Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/0024-3205(85)90440-0","volume":"36","author":"Mangat S.","year":"1985","unstructured":"Mangat S.; Patel H.M.; Lymph node localization of non-specific antibody-coated liposomes. Life Sci 1985,36(20),1917-1925","journal-title":"Life Sci"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.1080\/03639040500519102","volume":"32","author":"Ling S.S.","year":"2006","unstructured":"Ling S.S.; Magosso E.; Khan N.A.; Enhanced oral bioavailability and intestinal lymphatic transport of a hydrophilic drug using liposomes. Drug Dev Ind Pharm 0363-9045 (Print) 1520-5762 (Online)2006,32","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.3109\/1061186X.2010.551402","volume":"19","author":"Huang YB","year":"2011","unstructured":"Huang YB; Tsai MJ; Wu PC; Elastic liposomes as carriers for oral delivery and the brain distribution of (\u00fe)-catechin. J Drug Target 2011,19","journal-title":"J Drug Target"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.11.067","volume":"22","author":"Mann JFS","year":"2004","unstructured":"Mann JFS; Ferro VA; Mullen AB; Optimisation of a lipid based oral delivery system containing A\/Panama influenza haemagglutinin. Vaccine 2004,22","journal-title":"Vaccine"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(02)00411-X","volume":"86","author":"Takeuchi H","year":"2003","unstructured":"Takeuchi H; Matsui Y; Yamamoto H; Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in oral administration of calcitonin to rats. J Control Release 2003,86","journal-title":"J Control Release"},{"key":"ref=29","first-page":"247","volume":"11","author":"Zhang X.Y.","year":"2014","unstructured":"Zhang X.Y.; Lu W.Y.; Recent advances in lymphatic targeted drug delivery system for tumor metastasis. Cancer Biol Med 2014,11(4),247-254","journal-title":"Cancer Biol Med"},{"key":"ref=30","author":"Ghosh A.","unstructured":"Ghosh A.; Kaur C.D.; Gupta A.; Saraf S.; Surface engineered lamivudine loaded emulsome for targeting drug delivery to lymphatic system for effective treatment of hiv."},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ejps.2010.12.010","volume":"42","author":"Wu H.","year":"2011","unstructured":"Wu H.; Zhou A.; Lu C.; Wang L.; Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems. Eur J Pharm Sci 2011,42(4),348-353","journal-title":"Eur J Pharm Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1017\/S0031182006001612","volume":"134","author":"Gaur R.L.","year":"2007","unstructured":"Gaur R.L.; Dixit S.; Sahoo M.K.; Khanna M.; Singh S.; Murthy P.K.; Anti-filarial activity of novel formulations of albendazole against experimental brugian filariasis. Parasitology 2007,134(Pt 4),537-544","journal-title":"Parasitology"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijpharm.2008.07.032","volume":"364","author":"Joshi M.","year":"2008","unstructured":"Joshi M.; Pathak S.; Sharma S.; Patravale V.; Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether. Nanoject Int J Pharm 2008,364(1),119-126","journal-title":"Nanoject Int J Pharm"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3109\/1061186X.2014.950664","volume":"22","author":"Chaudhary S.","year":"2014","unstructured":"Chaudhary S.; Garg T.; Murthy R.S.; Rath G.; Goyal A.K.; Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. J Drug Target 2014,22(10),871-882","journal-title":"J Drug Target"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijpharm.2009.10.014","volume":"385","author":"Luo G.","year":"2010","unstructured":"Luo G.; Yu X.; Jin C.; Yang F.; Fu D.; Long J.; Xu J.; Zhan C.; Lu W.; LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors. Int J Pharm 2010,385(1-2),150-156","journal-title":"Int J Pharm"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejps.2010.10.002","volume":"42","author":"Aji Alex M.R.","year":"2011","unstructured":"Aji Alex M.R.; Chacko A.J.; Jose S.; Souto E.B.; Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur J Pharm Sci 2011,42(1-2),11-18","journal-title":"Eur J Pharm Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3390\/nano9091285","volume":"9","author":"Pavoni L.","year":"2019","unstructured":"Pavoni L.; Pavela R.; Cespi M.; Bonacucina G.; Maggi F.; Zeni V.; Canale A.; Lucchi A.; Bruschi F.; Benelli G.; Green Micro- and Nanoemulsions for Managing Parasites, Vectors and Pests. Nanomaterials (Basel) 2019,9(9),1285","journal-title":"Nanomaterials (Basel)"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1517\/17425247.2013.771630","volume":"10","author":"Ali M.","year":"2013","unstructured":"Ali M.; Afzal M.; Bhattacharya S.M.; Ahmad F.J.; Dinda A.K.; Nanopharmaceuticals to target antifilarials: a comprehensive review. Expert Opin Drug Deliv 2013,10(5),665-678","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jconrel.2006.01.006","volume":"112","author":"Reddy S.T.","year":"2006","unstructured":"Reddy S.T.; Rehor A.; Schmoekel H.G.; Hubbell J.A.; Swartz M.A.; In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release 2006,112(1),26-34","journal-title":"J Control Release"},{"key":"ref=40","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/986573","author":"Al-Abd N.M.","year":"2013","unstructured":"Al-Abd N.M.; Nor Z.M.; Al-Adhroey A.H.; Suhaimi A.; Sivanandam S.; Recent advances on the use of biochemical extracts as filaricidal agents. Evid Based Complement Alternat Med 2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=41","first-page":"4567","volume":"3","author":"Sahare K.N.","year":"2013","unstructured":"Sahare K.N.; Singh V.; In-vitro antifilarial activity of methanol extract of aegle marmelos corr. leaves. Indo American Journal of Pharmaceutical Research 2013,3(6),4567-4573","journal-title":"Indo American Journal of Pharmaceutical Research"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S1995-7645(14)60147-4","volume":"7","author":"Mukherjee N.","year":"2014","unstructured":"Mukherjee N.; Saini P.; Mukherjee S.; Roy P.; Sinha Babu S.P.; In vitro antifilarial activity of Azadirachta indica aqueous extract through reactive oxygen species enhancement. Asian Pac J Trop Med 2014,7(11),841-848","journal-title":"Asian Pac J Trop Med"},{"key":"ref=43","first-page":"1181","volume":"4","author":"Sahare K.N.","year":"2012","unstructured":"Sahare K.N.; Anandhraman V.; Meshram V.G.; Meshram S.U.; Singh V.; Reddy M.V.; Goswami K.; Antifilarial Potential of Butea monosperma L. against microfilaria in vitro. International Journal of PharmTech Research, ..0974- 43042012,4(3),1181-1184","journal-title":"International Journal of PharmTech Research,"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7243\/2054-9881-1-1","volume":"1","author":"Deshmukh M.","year":"2014","unstructured":"Deshmukh M.; Sahare K.N.; Patidar K.; Mahajan B.; Singh V.; Antifilarial activity of Butea monosperma L. leaves extracts against Setaria cervi. Trends in Vector Research and Parasitology 2014,1(1),1","journal-title":"Trends in Vector Research and Parasitology"},{"key":"ref=45","author":"Rizvi W","unstructured":"Rizvi W; Kumar A; Kumar R; Haider N; In-vitro screening for antifilarial potential in leaves of calotropis gigantae","journal-title":"In-vitro screening for antifilarial potential in leaves of calotropis gigantae"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3109\/1061186X.2013.869823","volume":"22","author":"Ali M.","year":"2014","unstructured":"Ali M.; Afzal M.; Abdul Nasim S.; Ahmad I.; Nanocurcumin: a novel antifilarial agent with DNA topoisomerase II inhibitory activity. J Drug Target 2014,22(5),395-407","journal-title":"J Drug Target"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s13071-016-1592-4","volume":"9","author":"Kushwaha V.","year":"2016","unstructured":"Kushwaha V.; Saxena K.; Verma R.; Verma S.K.; Katoch D.; Kumar N.; Lal B.; Murthy P.K.; Singh B.; Antifilarial activity of diterpenoids from Taxodium distichum. Parasit Vectors 2016,9(1),312","journal-title":"Parasit Vectors"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.3390\/molecules13092156","volume":"13","author":"Mathew N.","year":"2008","unstructured":"Mathew N.; Misra-Bhattacharya S.; Perumal V.; Muthuswamy K.; Antifilarial lead molecules isolated from Trachyspermum ammi. Molecules 2008,13(9),2156-2168","journal-title":"Molecules"},{"key":"ref=49","first-page":"88","volume":"4","author":"Sahare K.N.","year":"2015","unstructured":"Sahare K.N.; Singh V.; Antifilarial activity of Methanolic extract of Vitex negundo L. leaves against Setaria cervi filarial parasite. Sch Acad J Pharm (Online) ISSN 2347-9531 (Print)2015,4(2),88-92.2320-4206","journal-title":"Sch Acad J Pharm"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1995-7645(13)60119-4","volume":"6","author":"Sahare K.N.","year":"2013","unstructured":"Sahare K.N.; Singh V.; Antifilarial activity of ethyl acetate extract of Vitex negundo leaves in vitro. Asian Pac J Trop Med 2013,6(9),689-692","journal-title":"Asian Pac J Trop Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jconrel.2015.09.067","volume":"219","author":"Mitra A.K.","year":"2015","unstructured":"Mitra A.K.; Agrahari V.; Mandal A.; Cholkar K.; Natarajan C.; Shah S.; Joseph M.; Trinh H.M.; Vaishya R.; Yang X.; Hao Y.; Khurana V.; Pal D.; Novel delivery approaches for cancer therapeutics. J Control Release 2015,219,248-268","journal-title":"J Control Release"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/0972-9062.126428","volume":"50","author":"Sharma O.P.","year":"2013","unstructured":"Sharma O.P.; Vadlamudi Y.; Kota A.G.; Sinha V.K.; Kumar M.S.; Drug targets for lymphatic filariasis: a bioinformatics approach. J Vector Borne Dis 2013,50(3),155-162","journal-title":"J Vector Borne Dis"},{"key":"ref=53","author":"Kalyanasundaram R.","year":"2019","unstructured":"Kalyanasundaram R.; inventor; University of Illinois, assignee. Vaccine and methods for detecting and preventing filariasis. United States patent application US 16\/116,203. 7Feb; US Patent US 16\/116,2032019"},{"key":"ref=54","author":"Pfarr K.M.","year":"2015 27.Oct","unstructured":"Pfarr K.M.; Hoerauf A.; Koenig G.M.; Specht S.; Schiefer A.; Schaeberle T.F.; Schmitz A.; Kehraus S.; inventors; Rheinische Friedrich Wilhelms Universitaet Bonn, assignee. Compounds for use in the treatment of filariasis. United States patent US 9,168,244. US Patent US 9,168,2442015 27.Oct"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.provac.2010.11.003","volume":"3","author":"Samykutty A.","year":"2010","unstructured":"Samykutty A.; Dakshinamoorthy G.; Kalyanasundaram R.; Multivalent vaccine for lymphatic filariasis. Procedia Vaccinol 2010,3,12-18","journal-title":"Procedia Vaccinol"},{"key":"ref=56","author":"Baudonnet L.","year":"2012 13.Nov","unstructured":"Baudonnet L.; Mallard C.; inventors; Galderma SA, assignee. Dermatological compositions comprising avermectin nanocapsules. United States patent US 8,309,121. US Patent US 8,309,1212012 13.Nov"},{"key":"ref=57","author":"Mallard C.","year":"2013 23.Jul","unstructured":"Mallard C.; Baudonnet L.; inventors; Galderma SA, assignee. Dermatological compositions comprising avermectin nanocapsules. United States patent US 8,491,928. US Patent US 8,491,9282013 23.Jul"},{"key":"ref=58","year":"2012 4October","unstructured":"Indian Patent WO 2012\/131720 Al. Herbal composition and medicaments thereof for treatment of filariasis Hafiz Abdul2012 4October","journal-title":"Herbal composition and medicaments thereof for treatment of filariasis"},{"key":"ref=59","author":"Stewart G.C.","year":"2011 17.Nov","unstructured":"Stewart G.C.; Thompson B.M.; Lin C.H.; inventors; University of Missouri System, assignee Bacillus based delivery system and methods of use United States patent application US10081790B2, US Patent US10081790B22011 17.Nov","journal-title":"inventors; University of Missouri System, assignee Bacillus based delivery system and methods of use United States patent application US10081790B2,"},{"key":"ref=60","year":"2010 28.Jan","unstructured":"Method for rapid detection of lymphatic filariasisUnited States Patent US 2010\/0021926 A1 Noordin Rahmah2010 28.Jan","journal-title":"Method for rapid detection of lymphatic filariasisUnited States Patent US 2010\/0021926 A1"},{"key":"ref=61","author":"Goedemoed J.H.","year":"1999 9.Nov","unstructured":"Goedemoed J.H.; Hennink W.E.; inventors; Osteotech Inc, assignee Polyetherester copolymers as drug delivery matrices United States patent US 5,980,948 US Patent US 5,980,9481999 9.Nov","journal-title":"inventors; Osteotech Inc, assignee Polyetherester copolymers as drug delivery matrices United States patent US 5,980,948"},{"key":"ref=62","author":"Kron M.A.","year":"1998 24.Feb","unstructured":"Kron M.A.; Leberman R.; inventors; Europaisches Laboratorium fur Molekularbiologie (EMBL), Michigan State University, assignee Recombinant asparaginyl-tRNA synthetase from the human filarial parasite, Brugia malayi United States patent US 5,721,116 US Patent US 5,721,1161998 24.Feb","journal-title":"inventors; Europaisches Laboratorium fur Molekularbiologie (EMBL), Michigan State University, assignee Recombinant asparaginyl-tRNA synthetase from the human filarial parasite, Brugia malayi United States patent US 5,721,116"},{"key":"ref=63","author":"Friedheim E.A.","year":"1975 13.May","unstructured":"Friedheim E.A.; Duwel D.; inventors; Hoechst AG, assignee Treatment of filariasis United States patent US 3,883,650 US Patent US 3,883,6501975 13.May","journal-title":"inventors; Hoechst AG, assignee Treatment of filariasis United States patent US 3,883,650"},{"key":"ref=64","author":"Riviere E.","year":"1975 22.Apr","unstructured":"Riviere E.; Vilarel D.Y.; Debrie R.L.; Loiseau G.P.; inventors Treatment of bilharziosis and filariasis employing the antimony salt of certain hydroxy quinolines United States patent US 3,879,549 US Patent US 3,879,5491975 22.Apr","journal-title":"inventors Treatment of bilharziosis and filariasis employing the antimony salt of certain hydroxy quinolines United States patent US 3,879,549"},{"key":"ref=65","unstructured":"Disease Control Programmes [NHM] National Vector Borne Disease Control Programme Retrieved from,","journal-title":"Disease Control Programmes [NHM] National Vector Borne Disease Control Programme Retrieved from,"},{"key":"ref=66","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/103973","author":"Banerjee S.S.","year":"2012","unstructured":"Banerjee S.S.; Aher N.; Patil R.; Khandare J.; Poly (ethylene glycol)-prodrug conjugates: concept, design and applications. J Drug Deliv 2012","journal-title":"J Drug Deliv"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"34","DOI":"10.22270\/jddt.v2i3.164","volume":"2","author":"Ami M.","year":"2012","unstructured":"Ami M.; Krunal S.; Hejal P.; Advancements in controlled release gastroretentive drug delivery system: a review. J Drug Deliv Ther 2012,2(3),34-41","journal-title":"J Drug Deliv Ther"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0168-3659(02)00019-6","volume":"81","author":"Morishita M.","year":"2002","unstructured":"Morishita M.; Lowman A.M.; Takayama K.; Nagai T.; Peppas N.A.; Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers. J Control Release 2002,81(1-2),25-32","journal-title":"J Control Release"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1517\/17425247.2010.491508","volume":"7","author":"Bassi P.","year":"2010","unstructured":"Bassi P.; Kaur G.; pH modulation: a mechanism to obtain pH-independent drug release. Expert Opin Drug Deliv 2010,7(7),845-857","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1080\/21691401.2019.1577878","volume":"47","author":"Gour A.","year":"2019","unstructured":"Gour A.; Jain N.K.; Advances in green synthesis of nanoparticles. Artif Cells Nanomed Biotechnol 2019,47(1),844-851","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00436-017-5711-8","volume":"117","author":"Kumar D.","year":"2018","unstructured":"Kumar D.; Kumar G.; Agrawal V.; Green synthesis of silver nanoparticles using Holarrhena antidysenterica (L.) Wall.bark extract and their larvicidal activity against dengue and filariasis vectors. Parasitol Res 2018,117(2),377-389","journal-title":"Parasitol Res"},{"key":"ref=72","first-page":"13.2348","volume":"12","author":"Kanthammal S.","year":"2018","unstructured":"Kanthammal S.; Jebanesan A.; Kovendan K.; Subramaniam J.; Vijay M.; Novel insecticides of Syzygium cumini fabricated silver nanoparticles against filariasis, malaria, and dengue vector mosquitoes. methods (Mohanpuria et al., 2005; Rajan et al., 2015). 2018,12,13.2348-5906"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.addr.2011.05.020","volume":"63","author":"Nune S.K.","year":"2011","unstructured":"Nune S.K.; Gunda P.; Majeti B.K.; Thallapally P.K.; Forrest M.L.; Advances in lymphatic imaging and drug delivery. Adv Drug Deliv Rev 2011,63(10-11),876-885","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002351","volume":"7","author":"Landmann F.","year":"2011","unstructured":"Landmann F.; Voronin D.; Sullivan W.; Taylor M.J.; Anti-filarial activity of antibiotic therapy is due to extensive apoptosis after Wolbachia depletion from filarial nematodes. PLoS Pathog 2011,7(11)","journal-title":"PLoS Pathog"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/183297","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183297\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/183297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:36:24Z","timestamp":1723156584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183297\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,9,18]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450121666200630111250","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,18]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-12-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}